The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

HHS Secretary Robert F. Kennedy Jr named 8 new members to the CDC’s Advisory Committee on Immunization Practices.

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

today announced that data from the Company’s Phase 2a human challenge study of EDP-323 in healthy adults infected with respiratory syncytial virus (RSV) has been accepted for an oral ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates ... funded in part by the US Department of Health and Human Services Biomedical Advanced Research and ...

Statistically Significant Reduction in Viral Load Confirmed in Clinical Trial Primary Endpoint Achieved In the highest dose group, there was an 88.94% reduction in viral load (P<0.0001) OSAKA, Japan, ...

The human metapneumovirus ... in 2001 and is part of the Pneumoviridae family along with respiratory syncytial virus, or RSV, according to the CDC. It may have been circulating even earlier ...